Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The independent source for health policy research, polling, and news.
5,801 - 5,820 of 15,441 Results
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The new law, a response to escalating suicide rates among teens, is intended to ensure students know that immediate help is available if they need it.
Patients are often told to be smart consumers and shop around for health care before they use it. What happens when people actually take that advice?
Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.
The individual insurance market in Washington is dominated by companies that do business only in the Pacific Northwest, and the state’s insurance commissioner credits them with helping keep premium rates lower than in other states.
Thomas Insel, who ran the National Institute of Mental Health for 13 years before casting his lot with Silicon Valley, is taking a temporary break from his senior position at a health care startup to advise Gov. Gavin Newsom on how to remake mental health care in the Golden State.
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
In Utah, 85% of deaths from firearms are suicides. To help people who might be vulnerable, outreach workers are discussing suicide prevention at gun shows and firearms classes.
Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
Confusion about a new federal rule to restrict legal immigration based on the use of public benefits may dampen sign-ups for health care, housing and food aid even among immigrants not directly targeted by the rule. Here are some answers to frequently asked questions that will help clear up some of the misunderstanding.
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Talking about your mental health on social media is a thing, and it could actually help.
Wyoming is taking on expensive air ambulance bills by trying to expand Medicaid to cover transport for all patients. This is a big change: a red state seeking to control what's been a growing free-market bonanza.
In response to recent high-profile sex abuse cases, some California lawmakers want doctors to give patients more information about pelvic exams, and then get a signature proving they did. Doctors in the Golden State and beyond are pushing back.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
In an exclusive interview, a West Virginia physician says that back in 2015 he had a sense a patient’s illness “probably wasn't the first case ever seen nor would it be the last.” Was it a sentinel event?
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
© 2026 KFF